• The Korean Society of Law and Medicine
• /
• v.4 no.2
• /
• pp.225-248
• /
• 2003

• 동물약계
• /
• no.101
• /
• pp.2-3
• /
• 2005

[ $\cdot$ ]동물용의약품등 수입관리자 신규 승인$\cdot$동물용의약품등 제조$\cdot$수입업 폐업 신고 $\cdot$동물용의약품등 제조업 허가사항 변경 $\cdot$동물용의약품등 수입자 확인사항 변경 $\cdot$동물용의약품등취급규칙 개정(안) 입법예고 $\cdot$국립수의과학검역원 고시개정(안) 입안예고 $\cdot$약사법 위반사례 적발 조치 $\cdot$자가백신 생산시 신고방법 개선

• 동물약계
• /
• no.100
• /
• pp.2-3
• /
• 2005

[ $\cdot$ ]동물용의약품등 제조업 신규 허가 $\cdot$동물용의약품등 수입관리자 신규 승인$\cdot$동물용의약품등 제조$\cdot$수입업 폐업 신고 $\cdot$동물용의약품등 제조업 허가사항 변경 $\cdot$동물용의약품등 수입자 확인사항 변경 $\cdot$동물용의약품 제조업 휴업기간 연장 $\cdot$배합사료용동물용의약품등 사용기준 개정고시 $\cdot$동물용의약품등취급규칙 개정안 의견조회 $\cdot$약사법 위반 보조$\cdot$단미사료업체 형사고발

• The Korean Society of Law and Medicine
• /
• v.16 no.1
• /
• pp.191-219
• /
• 2015

The Japanese government has announced that it would invest 30 billion yen in iPS cell research for the next 10 year, and the Japan National Assembly has made an act that supports the iPS cell research. This study analyzes 1) the current trend and application field of stem cell research under Japan; 2) recent policy and regulation change in stem cell research and its application under Japan. This treatise reviews about "Act for Promoting Regenerative Medicine", "Act for Assuring Safety of Regenerative Medicine", and "the Revision of Pharmaceutical Act under Japan. This study may serve as the fundamental reference for the improvements of legal and institutional systems with regard to regulations on the stem cell research under Korea.

• The Korean Society of Law and Medicine
• /
• v.4 no.2
• /
• pp.272-298
• /
• 2003

• 건강소식
• /
• v.22 no.11 s.240
• /
• pp.40-41
• /
• 1998

• 건강소식
• /
• v.22 no.4 s.233
• /
• pp.36-37
• /
• 1998

• 건강소식
• /
• v.22 no.2 s.231
• /
• pp.36-37
• /
• 1998

• 건강소식
• /
• v.22 no.7 s.236
• /
• pp.40-41
• /
• 1998

• 건강소식
• /
• v.22 no.3 s.232
• /
• pp.36-37
• /
• 1998